Quarterly report (Form 10-Q)
Boston Scientific 10-Q for Quarter ended Sep 30, 2026
Filing excerpt
Our gross profit was $3.428 billion during the third quarter of 2026, $3.542 billion during the third quarter of 2025, $10.890 billion for the first nine months of 2026, and $10.175 billion for the first nine months of 2025.